Skip to main content
Clinical Trials/NCT00444821
NCT00444821
Terminated
Not Applicable

Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL)

Medtronic Cardiovascular63 sites in 1 country728 target enrollmentMarch 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ABDOMINAL AORTIC ANEURYSMS
Sponsor
Medtronic Cardiovascular
Enrollment
728
Locations
63
Primary Endpoint
Number of Subjects That Experienced Rupture or Aneurysm Related Death
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.

Registry
clinicaltrials.gov
Start Date
March 2005
End Date
January 2010
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Medtronic Cardiovascular
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 40 to 90 years of age
  • Meet all indications for use as stated in the Medtronic Vascular AAA Endograft Instructions for Use
  • Maximum aneurysm diameter of 4-5cm
  • If female patient with child bearing potential, must have a documented negative pregnancy test within seven(7)days prior to inclusion
  • Patient is willing and able to comply with the specified follow-up evaluation
  • Life expectancy at least 3 years

Exclusion Criteria

  • Meet any of the Contraindications stated in the Medtronic Vascular AAA Endograft instructions for Use
  • Known co-existing condition with a life expectancy of less than 3 years
  • Major surgical or interventional procedure (vascular and/or non-vascular)within 30 days prior to study enrollment
  • Subjects enrolled in another clinical trial or anticipated to be included into a trial, which may interfere with this study, or subjects already enrolled in this trial before.
  • Planned conduit procedure for introduction of endograft

Outcomes

Primary Outcomes

Number of Subjects That Experienced Rupture or Aneurysm Related Death

Time Frame: 3 years

Secondary Outcomes

  • Aneurysm Growth >0.5 cm(1 year)
  • Secondary Endovascular Procedures Between the 30-day Post Treatment and 3-year Follow-up(study termination)

Study Sites (63)

Loading locations...

Similar Trials